Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BCRX BioCryst Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $8.51 -0.7% | $15.05 -3.4% |
| StockIQ Score | 57C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 27F | 13F |
| Fundamental | 71B | 35F |
| Growth | 74B | 50C- |
| Fair Value | 55C | 38F |
| News | 80A- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BioCryst Pharmaceuticals (BCRX) outperforms Ascentage Pharma (AAPG) across most categories. BCRX has a stronger investor score (65 vs. 37), higher technical (51 vs. 18), fundamental (71 vs. 35), and growth scores (74 vs. 50), while AAPG’s valuation score (38) is slightly better than BCRX’s (55). BCRX also carries a "Moderate" rating, compared to AAPG’s "Weak."
